Product Name
AP-2 beta (TFAP2B), Polyclonal Antibody
Full Product Name
AP-2 beta
Product Synonym Names
Anti -AP-2 beta
Product Gene Name
anti-TFAP2B antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
chromosome: 6; Location: 6p12
3D Structure
ModBase 3D Structure for Q92481
Species Reactivity
Human, Mouse, Rat
Specificity
Detects endogenous levels of total human AP-2 beta protein at 49kD. Species Crossreactivity: mouse and rat.
Purity/Purification
Affinity Purified
Purified by Protein A affinity chromatography.
Form/Format
Supplied as a liquid in 10mM sodium HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol.
Immunogen
Synthetic peptide derived from the sequence of human AP-2 beta (KLH).
Preparation and Storage
May be stored at 4 degree C for short-term only. For long-term storage, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of anti-TFAP2B antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-TFAP2B antibody
The sequence-specific transcription factor activator protein 2 beta (AP-2 beta) is required for normal kidney development (1). AP-2 beta knockout mice die 1-2 days after birth due to polycystic kidney disease (1). Massive apoptosis occured during kidney deveopment at the end of embryogenesis in these mice (1). Overexpressed AP-2 beta has been to found to suppress c-myc-induced apoptosis, indicating a role of this transcription factor in cell survival (1). In addition, overexpression of AP-2 beta is shown to be related to impaired insulin signaling in adipocytes, and is therefore proposed to be a candidate gene that may relate to obesity (2).
Product Categories/Family for anti-TFAP2B antibody
Antibodies; Abs to Transcription Factors
Applications Tested/Suitable for anti-TFAP2B antibody
ELISA (EL/EIA), Western Blot (WB), Immunoprecipitation (IP), Immunofluorescence (IF)
Application Notes for anti-TFAP2B antibody
Suitable for use in Immunofluorescence, ELISA, Western Blot and Immunoprecipitation.
Dilution: Western Blot 1:1000
Immunoprecipitation 1:100
Immunofluorescence (IF-IC) 1:100
NCBI/Uniprot data below describe general gene information for TFAP2B. It may not necessarily be applicable to this product.
UniProt Primary Accession #
Q92481
[Other Products]
UniProt Secondary Accession #
Q5JYX6; Q9NQ63; Q9NU99; Q9UJI7; Q9Y214; Q9Y3K3[Other Products]
UniProt Related Accession #
Q92481[Other Products]
Molecular Weight
50,474 Da[Similar Products]
NCBI Official Full Name
AP-2 beta
NCBI Official Synonym Full Names
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
NCBI Official Symbol
TFAP2B??[Similar Products]
NCBI Official Synonym Symbols
AP-2B; AP2-B; MGC21381; TFAP2B
??[Similar Products]
NCBI Protein Information
transcription factor AP-2-beta; AP2-beta; activating enhancer binding protein 2 beta; activating enhancer-binding protein 2-beta
UniProt Protein Name
Transcription factor AP-2-beta
UniProt Synonym Protein Names
Activating enhancer-binding protein 2-beta
Protein Family
Transcription factor
UniProt Gene Name
TFAP2B??[Similar Products]
UniProt Entry Name
AP2B_HUMAN
NCBI Summary for TFAP2B
This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq]
UniProt Comments for TFAP2B
AP-2 beta: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important
biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia. Binds DNA as a dimer. Can form homodimers or heterodimers with other AP-2 family members. Interacts with CITED4. Interacts with UBE2I. Interacts with KCTD1; this interaction represses transcription activation. Interacts with CITED2 (via C-terminus); the interaction stimulates TFAP2B-transcriptional activity. Belongs to the AP-2 family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 6p12
Cellular Component: nucleus
Molecular Function: protein dimerization activity; protein binding; protein homodimerization activity; DNA binding; protein heterodimerization activity; sequence-specific DNA binding; transcription coactivator activity; caspase inhibitor activity; chromatin binding; transcription corepressor activity; transcription factor activity
Biological Process: skin development; fat cell differentiation; transcription from RNA polymerase II promoter; hindlimb morphogenesis; response to lithium ion; positive regulation of transcription, DNA-dependent; regulation of BMP signaling pathway; negative regulation of transcription from RNA polymerase II promoter; negative regulation of caspase activity; glucose homeostasis; calcium ion homeostasis; forelimb morphogenesis; negative regulation of cell proliferation; sympathetic nervous system development; regulation of transcription, DNA-dependent; regulation of cell differentiation; positive regulation of neuron apoptosis; positive regulation of cell proliferation; sodium ion homeostasis; phosphate ion homeostasis; negative regulation of neuron apoptosis; kidney development; potassium ion homeostasis; response to drug; glucose metabolic process; renal water homeostasis; positive regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; regulation of insulin secretion; negative regulation of apoptosis
Disease: Char Syndrome
Research Articles on TFAP2B
1. The present study identifies TFAP2b as a suggestive candidate gene in alcohol dependence.
2. Reduction of TFAP2B expression could have a protective effect against future risk of complications associated with decreased insulin sensitivity and central adiposity, such as type 2 diabetes and coronary heart disease.
3. TFAP2B, LYPLAL1 and MSRA are associated with adiposity and fat distribution.
4. Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)
5. Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
6. Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus is reported.
7. a potential usefulness of AP-2beta polymorphisms in explaining or predicting central nervous diseases, drug effects and side effects.
8. Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)
9. Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
10. Observational study of gene-disease association. (HuGE Navigator)
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.